2023-02-03 07:17:16 UI Ubiquiti
02/03/23 02/0307:17 02/03/2307:17 | Ubiquiti reports Q2 EPS $1.87 vs. $1.66 last yearReports Q2 revenue $493.6M vs. $431.6M last year. The company said, "We continue to experience significant supply constraints caused, in part, by the COVID-19 pandemic. The continued duration of these supply constraints remains uncertain. Our efforts to mitigate these supply constraints have included, for example, increasing our inventory build in an attempt to secure supply and meet customer demand, paying higher component and shipping costs to secure supply and modifying our product designs to leverage alternate suppliers. Although these mitigation efforts are intended to optimize our access to the components required to meet customer demand for our products, they have increased, and are expected to continue to increase, our balances of finished goods and raw material inventories. The increasing balance of finished goods and raw material inventory significantly increases the risks of future material excess, obsolete inventory and related losses. We believe that we are taking the right actions to mitigate these continuing supply constraints, however, we recognize the associated risks." |
---|
Initiation
|
Ingenia Communities initiated with a Buy at Citi »
19:19 03/27/23 03/2719:19 03/27/2319:19
INGEF
Ingenia Communities
Citi initiated coverage… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Joann price target lowered to $1 from $3.50 at BofA »
19:19 03/27/23 03/2719:19 03/27/2319:19
JOAN
Joann
BofA analyst Elizabeth… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Alps Alpine downgraded to Neutral from Buy at Citi »
19:18 03/27/23 03/2719:18 03/27/2319:18
APELY
Alps Alpine
Citi analyst Takayuki… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
BioNTech price target lowered to $194 from $239 at BofA »
19:17 03/27/23 03/2719:17 03/27/2319:17
BNTX
BioNTech
BofA lowered the… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Amicus price target raised to $17 from $16 at BofA »
19:16 03/27/23 03/2719:16 03/27/2319:16
FOLD
Amicus
BofA analyst Tazeen Ahmad… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Tencent price target raised to $50 from $48 at Barclays »
19:14 03/27/23 03/2719:14 03/27/2319:14
TCEHY
Tencent
Barclays analyst Jiong… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Lululemon price target lowered to $368 from $394 at Barclays »
19:13 03/27/23 03/2719:13 03/27/2319:13
LULU
Lululemon
Barclays lowered the… Story temporarily locked. ShowHide Related Items >><<
|
Upgrade
|
Parsons upgraded to Outperform from Market Perform at William Blair »
19:09 03/27/23 03/2719:09 03/27/2319:09
PSN
Parsons
William Blair analyst… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Liontown Resources rejects Albemarle's A$2.50 per share proposal »
18:59 03/27/23 03/2718:59 03/27/2318:59
LINRF
Liontown Resources
Albemarle
On March 27, 2023,… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
AnaptysBio 'encouraged' by GSK phase 3 trial results »
18:54 03/27/23 03/2718:54 03/27/2318:54
ANAB
AnaptysBio
GSK
AnaptysBio (ANAB)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Berkshire Hathaway acquires over 4.4M Occidental shares »
18:52 03/27/23 03/2718:52 03/27/2318:52
BRK.A
Berkshire Hathaway
Berkshire Hathaway
Occidental Petroleum
In a regulatory filing,… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
GSK says Phase III Ruby trial demonstrates Jemperli plus chemotherapy potential »
18:22 03/27/23 03/2718:22 03/27/2318:22
GSK
GSK
GSK announced interim… Story temporarily locked. ShowHide Related Items >><<
|
Periodicals
|
Judge says Amazon must face consumer antitrust suit, Reuters reports »
18:03 03/27/23 03/2718:03 03/27/2318:03
AMZN
Amazon.com
U.S. District Judge… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Tejon Ranch considering options to proceed with development of Centennial »
17:58 03/27/23 03/2717:58 03/27/2317:58
TRC
Tejon Ranch
Los Angeles Superior… Story temporarily locked. ShowHide Related Items >><<
|
On The Fly
|
Fly Intel: After-Hours Movers »
17:57 03/27/23 03/2717:57 03/27/2317:57
PVH
PVH Corp.
Lyft
FreightCar America
HIGHER AFTER EARNINGS … ShowHide Related Items >><<
|
Hot Stocks
|
TD Synnex names John Henry chief accounting officer »
17:53 03/27/23 03/2717:53 03/27/2317:53
SNX
TD Synnex
According to a regulatory… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
StarTek reports Q4 adjusted EPS 35c vs 32c last year »
17:52 03/27/23 03/2717:52 03/27/2317:52
SRT
StarTek
Reports Q4 revenue $92.96… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
FreightCar America sees FY23 revenue $400M-$430M »
17:48 03/27/23 03/2717:48 03/27/2317:48
RAIL
FreightCar America
Sees FY23 adjusted EBITDA… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
FreightCar America reports Q4 adjusted EPS (31c), two estimates (11c) »
17:48 03/27/23 03/2717:48 03/27/2317:48
RAIL
FreightCar America
Reports Q4 revenue $129M,… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Retractable Technologies cuts workforce by roughly 22% »
17:37 03/27/23 03/2717:37 03/27/2317:37
RVP
Retractable Technologies
Retractable Technologies… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Excelerate Energy sees FY23 adjusted EBITDA $320M-$340M
17:37 03/27/23 03/2717:37 03/27/2317:37
EE
Excelerate Energy
ShowHide Related Items >><<
|
Earnings
|
Excelerate Energy reports Q4 EPS 25c, consensus 22c »
17:36 03/27/23 03/2717:36 03/27/2317:36
EE
Excelerate Energy
Reports Q4 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Monopar Therapeutics Inc trading resumes
17:30 03/27/23 03/2717:30 03/27/2317:30
MNPR
Monopar Therapeutics
ShowHide Related Items >><<
|
Hot Stocks
|
Lockheed Martin awarded $210.09M government contract »
17:24 03/27/23 03/2717:24 03/27/2317:24
LMT
Lockheed Martin
Lockheed Martin was… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Merck reports NRG-GY018 trial shows statistical significance, improvement in PFS »
17:22 03/27/23 03/2717:22 03/27/2317:22
MRK
Merck
Merck announced results… Story temporarily locked. ShowHide Related Items >><<
|